Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Income from Continuing Operations (2022 - 2025)

Historic Income from Continuing Operations for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$6.2 million.

  • Envoy Medical's Income from Continuing Operations fell 1800.99% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.4 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of -$20.1 million for FY2024, which is 933.06% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Income from Continuing Operations is -$6.2 million, which was down 1800.99% from -$5.7 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Income from Continuing Operations ranged from a high of $12.5 million in Q1 2022 and a low of -$6.7 million during Q4 2023
  • Moreover, its 4-year median value for Income from Continuing Operations was -$4.9 million (2024), whereas its average is -$1.9 million.
  • The largest annual percentage gain for Envoy Medical's Income from Continuing Operations in the last 5 years was 2662.5% (2024), contrasted with its biggest fall of 78552.22% (2024).
  • Over the past 4 years, Envoy Medical's Income from Continuing Operations (Quarter) stood at -$2.0 million in 2022, then plummeted by 234.69% to -$6.7 million in 2023, then grew by 26.63% to -$4.9 million in 2024, then dropped by 25.26% to -$6.2 million in 2025.
  • Its last three reported values are -$6.2 million in Q3 2025, -$5.7 million for Q2 2025, and -$5.6 million during Q1 2025.